Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

the lawmakers said insulin was a "critical public health need" and they reminded them that patients with Type 1 diabetes need steady access to short-acting insulin. Which insulin brands are in ...

23 letters to CEOs of the three pharmaceutical giants, the lawmakers said insulin was a "critical public health need" and ...

Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

But it looks unlikely that Lilly will be able to maintain this with the launch of Humalog, which is available in vial form or as a disposable pen ... approved its short-acting insulin, Fiasp ...

“It doesn’t ever stop.” People with type 1 and some with type 2 can face multiple daily injections of insulin. Short-acting insulin covers the spike in glucose that comes with meal ...

A doctor and honorary researcher at the University of Exeter is leading a campaign to make reusable insulin pens the standard for treating diabetes patients. Dr Vincent Simpson aims to cut down on ...

Advantages of using insulin pens Long-acting insulin analogues offer several ... accurate and user-friendly,” she noted. They ...

“The combination of these two features should allow for more aggressive insulin titration without increasing the risk of hypoglycemia. This could improve both the short-term and long-term risks ...

Most insulin-dependent diabetics need to use both a short-acting and long-acting insulin to control their diabetes. "The long-acting insulin is injected once a day to provide a 'ceiling' of ...

23 letters to CEOs of the three pharmaceutical giants, the lawmakers said insulin was a "critical public health need" and they reminded them that patients with Type 1 diabetes need short-acting ...